First effective jab for malaria


Researchers at the Jenner Institute of Oxford University, UK, have developed the first malaria vaccine that meets international standards of effectiveness.


The vaccine showed up to 77% efficacy (the World Health Organization (WHO) requires a level of 75% effectiveness) in an African trial of 450 children in Burkina Faso - according to the latest WHO figures, more than 400,000 people a year die of malaria.


The findings from the phase two trial were based on previous work using mice, which showed a high immune response to the vaccine.


This Oxford team is the same as the one that was behind the Covid-19 AstraZeneca (AZ) jab.


Highlighting the value of investing in research, Gareth Jenkins, of Malaria No MoretoldThe Guardian: “The Jenner Institute’s groundbreaking work on both the AZ Covid-19 and malaria vaccine is a great example of this and demonstrates just how much humanity’s safety is dependent on new science.”

World Malaria Day 2021, was celebrated yesterday.

Recent Posts

See All